Evidence map›Paper›PMID 40464115›Full record

ArticleJournal of cosmetic dermatology2025

The Versatile Applications of Triple-Wavelength Diode Laser (810, 940, and 1060 nm) in Aesthetic Treatments, Follicular Disorders, and Chronic Inflammatory Conditions in the Asian Population: Case Report Collection.

Anuj Pall

Abstract readCase Reports
In one paragraph

Article in Journal of cosmetic dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Anuj PallEscallent Institute of Lasers and Aesthetic Medicine (EILAM), Gurugram, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSingle-wavelength lasers (755 or 810 nm) are widely used to remove unwanted hair. Recently, combined-wavelength diode lasers have been introduced to improve the safety of darker skin types, owing to their varying absorption spectra and penetration depths. However, their application beyond hair removal remains unclear.

aimsThis study aimed to evaluate the efficacy of a high-power triple-wavelength diode laser (810, 940, and 1060 nm) in treating hirsutism, inflammatory follicular disorders, and aesthetic concerns such as hairline enhancement in darker skin types. PATIENTS/

methodsThis retrospective study was conducted at the Escallent Institute of Lasers & Aesthetic Medicine (EILAM), Gurugam, India, using a Primelase device with a triple-wavelength diode laser. The study involved adults with skin type IV who presented with facial hirsutism and follicular disorders, including trichostasis spinulosa, pilonidal sinus disease, and hidradenitis suppurativa. Efficacy was assessed using hair counting and the Global Aesthetic Improvement Scale (GAIS), whereas safety was evaluated based on reported adverse effects, such as pain, erythema, and edema.

resultsThe GAIS scores indicated a mean improvement of 3.4 ± 0.4 out of 4, representing a 50%-75% improvement. Hair counting revealed a statistically significant hair reduction of 82.9% ± 15.4%, with reductions ranging from 56% to 100%. No adverse events were observed.

conclusionThe high-power triple-wavelength diode laser demonstrated both efficacy and safety in treating facial hirsutism and other follicular disorders as well as aesthetic concerns such as hairline enhancement, particularly in darker skin tones.

Indexed as

Hair RemovalHirsutismLasers, SemiconductorLow-Level Light TherapyAdultEstheticsFaceFemaleHidradenitis SuppurativaHumansIndiaMaleMiddle AgedRetrospective StudiesSkin PigmentationTreatment Outcomeblend wavelengthdark skin typesdiode laserhair removalhidradenitis suppurativapilonidal sinustrichostasis spinulosa

Identifiers

PMID40464115
PMCPMC12135030

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.